11/20
05:01 pm
syrs
Form 4 Syros Pharmaceuticals, For: Nov 19 Filed by: Quirk Gerald E
Low
Report
Form 4 Syros Pharmaceuticals, For: Nov 19 Filed by: Quirk Gerald E
11/20
05:01 pm
syrs
Form 4 Syros Pharmaceuticals, For: Nov 18 Filed by: Stephens Kristin
Low
Report
Form 4 Syros Pharmaceuticals, For: Nov 18 Filed by: Stephens Kristin
11/20
05:00 pm
syrs
Form 4 Syros Pharmaceuticals, For: Nov 18 Filed by: Chee Conley
Low
Report
Form 4 Syros Pharmaceuticals, For: Nov 18 Filed by: Chee Conley
11/20
05:00 pm
syrs
Form 4 Syros Pharmaceuticals, For: Nov 18 Filed by: Roth David
Low
Report
Form 4 Syros Pharmaceuticals, For: Nov 18 Filed by: Roth David
11/20
05:00 pm
syrs
Form 4 Syros Pharmaceuticals, For: Nov 18 Filed by: Haas Jason
Low
Report
Form 4 Syros Pharmaceuticals, For: Nov 18 Filed by: Haas Jason
11/19
05:22 pm
syrs
Form 144 Syros Pharmaceuticals, Filed by: Quirk Gerald E
High
Report
Form 144 Syros Pharmaceuticals, Filed by: Quirk Gerald E
11/18
06:01 pm
syrs
Form 144 Syros Pharmaceuticals, Filed by: Haas Jason
High
Report
Form 144 Syros Pharmaceuticals, Filed by: Haas Jason
11/18
05:43 pm
syrs
Form 144 Syros Pharmaceuticals, Filed by: Roth David
High
Report
Form 144 Syros Pharmaceuticals, Filed by: Roth David
11/18
05:21 pm
syrs
Form 144 Syros Pharmaceuticals, Filed by: Stephens Kristin
High
Report
Form 144 Syros Pharmaceuticals, Filed by: Stephens Kristin
11/18
04:46 pm
syrs
Form 144 Syros Pharmaceuticals, Filed by: Chee Conley
High
Report
Form 144 Syros Pharmaceuticals, Filed by: Chee Conley
11/18
04:19 pm
syrs
Form 144 Syros Pharmaceuticals, Filed by: Haas Jason
High
Report
Form 144 Syros Pharmaceuticals, Filed by: Haas Jason
11/18
12:09 pm
syrs
Form 144 Syros Pharmaceuticals, Filed by: Chee Conley
Low
Report
Form 144 Syros Pharmaceuticals, Filed by: Chee Conley
11/18
07:02 am
syrs
Form 8-K Syros Pharmaceuticals, For: Nov 12
High
Report
Form 8-K Syros Pharmaceuticals, For: Nov 12
11/14
05:28 pm
syrs
Form SC 13G/A Syros Pharmaceuticals, Filed by: Avidity Partners Management LP
Medium
Report
Form SC 13G/A Syros Pharmaceuticals, Filed by: Avidity Partners Management LP
11/14
05:25 pm
syrs
Form SC 13G/A Syros Pharmaceuticals, Filed by: Bain Capital Life Sciences Fund II, L.P.
Medium
Report
Form SC 13G/A Syros Pharmaceuticals, Filed by: Bain Capital Life Sciences Fund II, L.P.
11/14
05:06 pm
syrs
Form SC 13G/A Syros Pharmaceuticals, Filed by: Blue Owl Capital Holdings LP
Medium
Report
Form SC 13G/A Syros Pharmaceuticals, Filed by: Blue Owl Capital Holdings LP
11/4
05:02 pm
syrs
Form 4 Syros Pharmaceuticals, For: Oct 31 Filed by: Roth David
Medium
Report
Form 4 Syros Pharmaceuticals, For: Oct 31 Filed by: Roth David
11/4
05:02 pm
syrs
Form 4 Syros Pharmaceuticals, For: Oct 31 Filed by: Simonian Nancy A
Medium
Report
Form 4 Syros Pharmaceuticals, For: Oct 31 Filed by: Simonian Nancy A
11/4
05:01 pm
syrs
Form 4 Syros Pharmaceuticals, For: Oct 31 Filed by: Haas Jason
Medium
Report
Form 4 Syros Pharmaceuticals, For: Oct 31 Filed by: Haas Jason
11/4
05:01 pm
syrs
Form 4 Syros Pharmaceuticals, For: Oct 31 Filed by: Chee Conley
Medium
Report
Form 4 Syros Pharmaceuticals, For: Oct 31 Filed by: Chee Conley
11/4
05:01 pm
syrs
Form 4 Syros Pharmaceuticals, For: Oct 31 Filed by: Stephens Kristin
Medium
Report
Form 4 Syros Pharmaceuticals, For: Oct 31 Filed by: Stephens Kristin
10/31
06:50 am
syrs
Form 10-Q Syros Pharmaceuticals, For: Sep 30
Low
Report
Form 10-Q Syros Pharmaceuticals, For: Sep 30
10/2
05:00 pm
syrs
Form 4 Syros Pharmaceuticals, For: Sep 30 Filed by: Quirk Gerald E
Low
Report
Form 4 Syros Pharmaceuticals, For: Sep 30 Filed by: Quirk Gerald E
9/18
05:00 pm
syrs
Form 4 Syros Pharmaceuticals, For: Sep 16 Filed by: Young Richard A
Neutral
Report
Form 4 Syros Pharmaceuticals, For: Sep 16 Filed by: Young Richard A
9/18
05:00 pm
syrs
Form 4 Syros Pharmaceuticals, For: Sep 16 Filed by: AKKARAJU SRINIVAS
Neutral
Report
Form 4 Syros Pharmaceuticals, For: Sep 16 Filed by: AKKARAJU SRINIVAS